Quick Answer
CTT PHARMACEUTICAL HOLDINGS, INC. reported Net Income Loss of $227.8 thousand for the year ending 2014.
- CTT PHARMACEUTICAL HOLDINGS, INC. showed an increase of +1,304.8% in Net Income Loss from 2013 to 2014.
- This data is from CTT PHARMACEUTICAL HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on April 14, 2015.
- XBRL data for this metric is available from 2010 to 2014 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: -$1.4 thousand | Q3 2010: -$442.3 thousand | Q1 2011: $5.69 million | Q2 2011: -$1.08 million | Q3 2011: -$442.1 thousand | Q1 2012: -$582.4 thousand | Q2 2012: -$35.6 thousand | Q3 2012: -$109.0 thousand | Q1 2013: -$40.4 thousand | Q2 2013: -$63.7 thousand | Q3 2013: -$8.5 thousand | Q1 2014: -$1.7 thousand | Q2 2014: -$920.00 | Q3 2014: -$43.2 thousand | Q1 2015: -$337.1 thousand | Q2 2015: -$362.7 thousand | Q3 2015: -$341.9 thousand.
- Over the full 5 years of available data (2010 to 2014), CTT PHARMACEUTICAL HOLDINGS, INC.'s Net Income Loss has grown by 120.8%.
- Historical annual values: Fiscal year 2014: $227.8 thousand | Fiscal year 2013: -$18.9 thousand | Fiscal year 2012: -$1.00 million | Fiscal year 2011: $3.74 million | Fiscal year 2010: -$1.10 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: